Bioseeker

BioSeeker Group is an independent, privately owned company based in Sweden since 1999. They focus on business, competitive intelligence in oncology and operate in two business areas: consulting and publishing. BioSeekers Group's mission is to excel our customer's business operations by objective and unbiased research and analysis.

Results 1 - 20 of 63

previous 1 2 3 4 next

Title	Date	Price
Cancer Antibodies: Competitive Positioning for Success	Jun 2008	£1,555
Cancer Vaccines: Aim and Shoot	May 2008	£1,555
The Deployment of Antibody Technologies for the Advancement of Cancer Therapeutics	Apr 2008	£1,790
The Drug Target Atlas of Protein Kinase Inhibitors in Oncology	Nov 2007	£2,930
Decoding Big Pharma's R&D Strategy in Oncology	Sep 2007	£1,950
Decoding Big Pharmas R&D Strategy in Oncology	Sep 2007	£2,930
Melanoma - Targeted Therapeutics	Jul 2007	£1,555
Analytical Tool - Targeted Therapeutics: Melanoma	Jul 2007	£2,470
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Melanoma and NSCLC	Jul 2007	£4,125
Antibody Drug Target Atlas in Oncology	Jun 2007	£2,730
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Leukemias and Lymphomas	Jun 2007	£4,125
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Breast- and Prostate Cancer	Jun 2007	£4,125
Analytical Tool - Prostate Cancer A Therapeutic & Competitive Insight	May 2007	£2,470
Cancer Vaccines Drug Pipeline Update 2007	May 2007	£1,195
Prostate Cancer Drug Pipeline Update 2007	May 2007	£1,195
Leukemia Drug Pipeline Update 2007	May 2007	£1,195
Apoptosis in Oncology Drug Pipeline Update 2007	May 2007	£1,195
Hematological Cancers Drug Pipeline Update 2007	May 2007	£1,590
Analytical Tool - Leukemia Therapeutics & Competitive Insights	May 2007	£2,470
Angiogenesis in Oncology Drug Pipeline Update 2007	May 2007	£1,195